Drugs / CBD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01610687 | Jul 2001 → Feb 2005 | multiple sclerosis | Jazz Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | “Contained THC and CBD as extract of Cannabis sativa L. Each 100 μl actuation delivered a dose containing 2.7 mg THC and 2.5mg CBD.” NCT01610687 ↗ |
| Route | Other | “an oromucosal cannabis-based medicine (CBM)” PMID 17086911 ↗ Oct 2006 |